BACKGROUND: Early metastasis and infiltration are survival limiting characteristics of pancreatic ductal adenocarcinoma (PDAC). Thus, PDAC is likely to harbor alterations in metastasis suppressor genes that may provide novel diagnostic and therapeutic opportunities. This study investigates a panel of metastasis suppressor genes in correlation to PDAC phenotype and examines promoter methylation for regulatory influence on metastasis suppressor gene expression and for its potential as a diagnostic tool. METHODS: Metastatic and invasive potential of 16 PDAC cell lines were quantified in an orthotopic mouse model and mRNA expression of 11 metastasis suppressor genes determined by quantitative RT-PCR. Analysis for promoter methylation was perfor...
The importance of epigenetic modifications such as DNA methylation in tumorigenesis is increasingly ...
The importance of epigenetic modifications such as DNA methylation in tumorigenesis is increasingly ...
Pancreatic cancer has become the third leading cause of cancer-related death in the Western world de...
Background: Pancreatic ductal adenocarcinoma (PDAC) is distinguished by rapid dissemination. Thus, g...
Lin, Huey-JenAberrant DNA methylation of promoter CpG islands (CGI) is a contributing factor that fa...
Cancer is a complex disease with contributions from genetic and epigenetic modifications. Epigenetic...
Introduction: Only a small number of risk factors for pancreatic ductal adenocarcinoma (PDAC) has be...
INTRODUCTION: Only a small number of risk factors for pancreatic ductal adenocarcinoma (PDAC) has be...
INTRODUCTION: Only a small number of risk factors for pancreatic ductal adenocarcinoma (PDAC) has be...
To investigate the relationship between DNA hypomethylation and gene overexpression in pancreatic ca...
The importance of epigenetic modifications such as DNA methylation in tumorigenesis is increasingly ...
The importance of epigenetic modifications such as DNA methylation in tumorigenesis is increasingly ...
Promoter hypermethylation of the SMAD4 gene has been registered in some cancer types, but in general...
Promoter hypermethylation of the SMAD4 gene has been registered in some cancer types, but in general...
Promoter hypermethylation of the SMAD4 gene has been registered in some cancer types, but in general...
The importance of epigenetic modifications such as DNA methylation in tumorigenesis is increasingly ...
The importance of epigenetic modifications such as DNA methylation in tumorigenesis is increasingly ...
Pancreatic cancer has become the third leading cause of cancer-related death in the Western world de...
Background: Pancreatic ductal adenocarcinoma (PDAC) is distinguished by rapid dissemination. Thus, g...
Lin, Huey-JenAberrant DNA methylation of promoter CpG islands (CGI) is a contributing factor that fa...
Cancer is a complex disease with contributions from genetic and epigenetic modifications. Epigenetic...
Introduction: Only a small number of risk factors for pancreatic ductal adenocarcinoma (PDAC) has be...
INTRODUCTION: Only a small number of risk factors for pancreatic ductal adenocarcinoma (PDAC) has be...
INTRODUCTION: Only a small number of risk factors for pancreatic ductal adenocarcinoma (PDAC) has be...
To investigate the relationship between DNA hypomethylation and gene overexpression in pancreatic ca...
The importance of epigenetic modifications such as DNA methylation in tumorigenesis is increasingly ...
The importance of epigenetic modifications such as DNA methylation in tumorigenesis is increasingly ...
Promoter hypermethylation of the SMAD4 gene has been registered in some cancer types, but in general...
Promoter hypermethylation of the SMAD4 gene has been registered in some cancer types, but in general...
Promoter hypermethylation of the SMAD4 gene has been registered in some cancer types, but in general...
The importance of epigenetic modifications such as DNA methylation in tumorigenesis is increasingly ...
The importance of epigenetic modifications such as DNA methylation in tumorigenesis is increasingly ...
Pancreatic cancer has become the third leading cause of cancer-related death in the Western world de...